Concerned about ICER?
Precision has deep experience in the theory, practice and implications of value assessment—and has collaborated with pharmaceutical clients in responding to over 30 unique ICER reviews. Find out more >>
PHE combines the scientific thought leadership of academic experts with the practical insights of a professional consulting firm. PHE staff and advisors include a diverse team of economists, statisticians, epidemiologists, programmers, clinicians, and other methodological experts.
“Creative thinking benefits from a diversity of perspectives and approaches. At PHE, you’ll find some of the most innovative thinkers in the field of HEOR.” – Carolyn Harley, PhD, MPA
FEATURED THOUGHT LEADERSHIP
Restricting Access Based on ICER Estimates: Value Should Not Be One-Size-Fits-All
The recent announcement that CVS Caremark will use value-based metrics to inform formulary design at first appears a step in the right direction. However, using value measurements from a single nongovernmental organization—the Institute for Clinical and Economic Review (ICER)—based on a limited picture of treatment value may be problematic.